NOXA1 Knockout Cell Line - CD BioSciences

service-banner

NOXA1 Knockout Cell Line

NOXA1 Knockout Cell Line

SPL-02312

Size Price
1 Unit Online Inquiry
Description
1bp insertion
Target Information
Target Name NOXA1
Gene Abbr. NOXA1
Gene ID 10811
Full Name NADPH oxidase activator 1
Alias NY-CO-31, SDCCAG31, p51NOX
Species Human
Genomic Locus chr9:137426250
Transcript NM_006647
WT Expression Level 0.49 TPM (TPM = Transcripts per million; any value less than 3 is considered non-expressing)
Introduction This gene encodes a protein which activates NADPH oxidases, enzymes which catalyze a reaction generating reactive oxygen species. The encoded protein contains four N-terminal tetratricopeptide domains and a C-terminal Src homology 3 domain. Interaction between the encoded protein and proteins in the oxidase regulatory complex occur via the tetratricopeptide domains. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
Product Details
Cell Line Model HAP1
Genotype HAP1 cell line, edited by CRISPR/Cas to contain a 1bp insertion in a coding exon of NOXA1.
Description 1bp insertion
Parental Cell Line C631
Guide RNA Sequence ATTTGACCAAGCCGTGACCA
PCR Primer Forward: GTAAACACATTGGTTTTAGCAGCAC
Reverse: GACTCTGCAGGGAGACAAAGG
Handling Specifications
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into 10 mL of pre-warmed media in a 10 cm dish.
Culture Medium IMDM + 10% FCS
Growth Properties Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 2-3 days, splitting approximately 1:10-1:20.
Freeze Medium IMDM + 20% FCS + 10% DMSO
Biosafety Level BSL-1
Disclaimer This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.